Predict your next investment

Angel Investor (Group)
angelsforum.com

See what CB Insights has to offer

Investments

95

Portfolio Exits

17

Funds

1

About The Angels' Forum

The Angels' Forum (TAF) invests in, mentoring and advising Silicon Valley startups from the seed stage all the way through a meaningful exit. They are a diverse group of 25 high net worth private investors, all of whom have been CEO's, founders or senior executives of successful entrepreneurial ventures. We have the capital, time, experience, skills and passion to work with other entrepreneurs to build disruptive companies.

The Angels' Forum Headquarter Location

2665 Marine Way Suite 1150

Mountain View, California, 94043,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

The Angels' Forum Investments

95 Investments

The Angels' Forum has made 95 investments. Their latest investment was in RenovoRx as part of their Series D on May 5, 2018.

CBI Logo

The Angels' Forum Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/23/2018

Series D

RenovoRx

$10M

No

5

9/10/2014

Seed VC

Zephyrus Biosciences

$1.5M

Yes

2

6/11/2014

Series A

Bell Biosystems

$3.81M

Yes

4

5/13/2014

Series B

Subscribe to see more

$99M

Subscribe to see more

10

1/27/2014

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/23/2018

9/10/2014

6/11/2014

5/13/2014

1/27/2014

Round

Series D

Seed VC

Series A

Series B

Series B

Company

RenovoRx

Zephyrus Biosciences

Bell Biosystems

Subscribe to see more

Subscribe to see more

Amount

$10M

$1.5M

$3.81M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

2

4

10

10

The Angels' Forum Portfolio Exits

17 Portfolio Exits

The Angels' Forum has 17 portfolio exits. Their latest portfolio exit was RenovoRx on August 26, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/26/2021

IPO

$991

3

7/1/2017

Acquired

1

1/1/2017

Acquired

1

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

8/26/2021

7/1/2017

1/1/2017

00/00/0000

00/00/0000

Exit

IPO

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Sources

3

1

1

10

10

The Angels' Forum Fund History

1 Fund History

The Angels' Forum has 1 fund, including Angels' Forum.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/31/1997

Angels' Forum

Early-Stage Venture Capital

$31M

1

Closing Date

12/31/1997

Fund

Angels' Forum

Fund Type

Early-Stage Venture Capital

Status

Amount

$31M

Sources

1

The Angels' Forum Team

6 Team Members

The Angels' Forum has 6 team members, including former Chief Financial Officer, Mei Xu.

Name

Work History

Title

Status

Mei Xu

Chief Financial Officer

Former

Mike Lanham

Controller

Former

Peter Rosenthal

Founding Partner

Former

Laura Roden

Managing Director

Former

Jeffrey Yu

Crescendo Ventures

Managing Director

Former

Name

Mei Xu

Mike Lanham

Peter Rosenthal

Laura Roden

Jeffrey Yu

Work History

Crescendo Ventures

Title

Chief Financial Officer

Controller

Founding Partner

Managing Director

Managing Director

Status

Former

Former

Former

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.